News

Adaptimmune Announces Entry Into Definitive Agreement For Sale Of TECELRA, Lete-Cel, Afami-Cel And Uza-Cel Cell Therapies To US Worldmeds
Tecelra will continue to be available to patients without interruption US WorldMeds plans to bring lete-cel to market and will continue dev ...